Poland
a)
CFC and non-CFC metered dose
inhalers and dry-powder inhalers sold or distributed within Poland
|
Brand |
Active
ingredient
|
Manufacturer |
Import |
Domestic production |
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. |
CFC MDIs
Atrovent Beclazone
EB Beclocort Becotide Berodual Budesonid Cromogen Cropoz Flixotide Horacort Salamol Salbutamol Serevent Ventolin |
Ipratropii bromidum
Beclometasone dipropionate
Beclomatasone
dipropionate
Beclometasone dipropionate
Fenoteroli hydrobromidum
Budesonide
Natri cromoglicas
Natri cromoglicas
Fluticasone propionate
Budesonide
Salbutamol sulphate
Salbutamol sulphate
Salmeterol xinafonate
Salbutamol
sulphate
|
Boehringer Ingelh. Norton Healthcare GSK GSK Boehringer Ingelh. GSK Norton
Healthcare GSK GSK Pharmaceutical
Research
Institute Norton
Healthcare GSK
+ Norton GSK GSK |
* * * * * * |
* * * * * * * * |
1. 2. 3. 4. |
Non-CFC MDIs
Berotec
Flixotide
Seretide Ventolin |
Fenoteroli hydrobromide
Fluticasone
propionate Fluticasone
propionate +salmeterol xi Salbutamol sulphate |
Boehringer Ingelheim GSK GSK |
* * |
* * |
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. |
Dry-powder inhalers Becodisk
Flixotide Dysk
Foradil
Intal
Miflonide
Oxis
Pulmicort
Seretide Dysk
Serevent
Dysk
Ventodisks
|
Beclometasone
dipropionate Fluticasone
propionate Formoterol
fumaras Natri
cromoglicas Budesonide Formoteroli
furnaras Formoteroli
fumaras Fluticasone
propionate/salmeterol xi Salmeterol
xinafoate Salbutamol sulphate |
GSK
GSK
Novatis Pharma
Rhone-Poulenc
Novartis UK
AstraZeneca AB
AstraZeneca AB
GSK
GSK
GSK
|
* * * * * * * * * * * |
|
b)
CFC and non-CFC metered dose inhalers and dry-powder inhalers
produced in Poland for export to other Parties
|
Brand Name |
Active
ingredient
|
Manufacturer |
Importing
country
|
1. 2. 3. 4. 5. 6. 7. 8. |
CFC MDIs
Beclocort Becotide Budesonid Cropoz Flixotide Salbutamol Serevent Ventolin |
Beclometasone dipropionate
Beclometasone dipropionate
Budesonide
Natri cromoglicas
Fluticasone propionate
Salbutamol sulphate
Salmeterol
xinafonate
Salbutamol
sulphate
|
GSK GSK GSK GSK GSK GSK GSK GSK |
Various
European former socialist countries |
1. 2. 3. |
Non-CFC MDIs
Flixotide
Seretide Ventolin |
Fluticasone
propionate Fluticasone
propionate +salmeterol xi Salbutamol sulphate |
GSK GSK GSK |
Like
above
|
|
Dry-powder inhalers are not exported
|
|
|
|
c) Non-CFC metered dose inhalers and dry-powder inhalers
authorised for marketing and launched in the territory of Poland
|
Brand
Name |
Active
ingredient
|
Manufacturer |
Date approved |
Launched in Poland |
1. 2. 3. 4. |
Non-CFC MDIs
Berotec
Flixotide
Seretide Ventolin |
Fenoteroli hydrobromide
Fluticasone
propionate Fluticasone
propionate +salmeterol xi Salbutamol sulphate |
Boehringer Ingelheim GSK GSK GSK |
11.2000 12.2000 12.2001 09.1999 |
2001 2001 - 2000 |
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. |
Dry-powder inhalers Becodisk
Flixotide Dysk
Flixotide Rotadisk
Foradil
Intal
Miflonide
Oxis
Pulmicort
Seretide Dysk
Serevent
Dysk
Ventodisks
|
Beclometasone
dipropionate Fluticasone
propionate Fluticasone
propionate Formoteroli
furmaras Natri
cromoglicas Budesonide Formoteroli
furnaras Formoteroli
fumaras Fluticasone
propionate/salmeterol xi Salmeterol xinafoate Salbutamol sulphate |
GSK
GSK
GSK
Novatis Pharma
Rhone-Poulenc
Novartis UK
AstraZeneca AB
AstraZeneca AB
GSK
GSK
GSK
|
11.1992 12.2000 04.1996 10.1998 05.1999 04.2002 10.1999 08.2001 12.2001 05.1999 11.1992 |
1993 2001 1996 1999 2000 2002 2000 2001 - 2000 1993 |